cellvie Email Format

Biotechnology ResearchSwitzerland2-10 Employees

cellvie is a Swiss biotechnology company focused on Therapeutic Mitochondria Transplantation, an approach intended to augment or replace mitochondria within cells. The technology, developed by Dr. James McCully at Harvard Medical School, is being advanced from bench to bedside with an initial focus on heart attacks and solid organ transplantation. Based in Zürich, Switzerland, the company operates with a small team pursuing clinical translation of mitochondria-based therapies.

In November 2023, cellvie announced a partnership with CSEM to collaborate on advancing its mitochondria-based therapy platform. The collaboration aligns with the goal of expanding its European presence and advancing its research program.

Sign up for free to view info

Company overview Employee directory